High frequency of Vα24+ Vβ11+ T-cells observed in type 1 diabetes

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1818-1823

  Oikawa, Yoichi ^a   Shimada, Akira ^a   Yamada, Satoru ^a   Motohashi, Yoshiko ^a   Nakagawa, Yoshinori ^a   Irie, Jun Ichiro ^a   Maruyama, Taro ^b   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEASUREMENT; NATURAL KILLER CELL; T LYMPHOCYTE; ADULT; BLOOD; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; REFERENCE VALUE;

ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0036782361     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1818     Document Type: Article

References (38)

1. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG: Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 45:1063-1067, 1996
2. Lehuen A, Lantz O, Beaudoin L, Laloux V, Camaud C, Bendelac A, Bach JF, Monteiro RC: Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 188:1831-1839, 1998
3. - T cells in mice and humans. J Exp Med 180:1097-1106, 1994
4. - subset. J Exp Med 177:1763-1771, 1993
5. - T cells. J Exp Med 180:1171-1176, 1994
6. - alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178:1-16, 1993
7. - T cells. J Exp Med 186:109-120, 1997
8. Morita M, Motoki K, Akimoto K, Natori T, Sakai T, Sawa E, Yamaji K, Koezuka Y, Kobayashi E, Fukushima H: Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem 38:2176-2187, 1995
9. Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y: KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 7:529-534, 1995
10. Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, Koezuka Y, Van Kaer L: Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 169:31-44, 1999
11. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M: CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278:1626-1629, 1997
12. + NK T lymphocytes. J Immunol 161:3271-3281, 1998
13. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J Immunol 159:2240-2249, 1997
14. Yoshimoto T, Paul WE: CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 179:1285-1295, 1994
15. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A 92:11931-11934, 1995
16. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 156:4035-4040, 1996
17. Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S, Nishioka K, Iwamoto I, Taniguchi M: Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med 182:1163-1168, 1995
18. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 100:144-148, 2001
19. Sumida T, Maeda T, Taniguchi M, Nishioka K, Stohl W: TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus. Lupus 7:565-568, 1998
20. Yanagihara Y, Shiozawa K, Takai M, Kyogoku M, Shiozawa S: Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin Exp Immunol 118:131-136, 1999
21. - thymocytes. J Autoimmun 10:279-285, 1997
22. + -like thymocytes in the NOD mouse. Eur J Immunol 26:2989-2998, 1996
23. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
24. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187:1047-1056, 1998
25. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA: Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391:177-181, 1998
26. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
27. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
28. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
29. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
30. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T: High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J Autoimmun 12:131-135, 1999
31. - and heterogeneous with respect to TCR beta expression. Hum Immunol 48:63-67, 1996
32. Poulton LD, Baxter AG: Clinical application of NKT cell assays to the prediction of type 1 diabetes. Diabete Metab Res Rev 17:429-435, 2001
33. van Der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van Den Eertwegh AJ, Giaccone G, Miedema F, Scheper RJ, Pinedo HM: Selective decrease in circulating Valpha24(+)Vbeta11(+) NKT cells during HIV type 1 infection. J Immunol 168:1490-1495, 2002
34. - T cells bearing T-cell receptor alpha and beta chains in two normal men. Blood 79:2965-2972, 1992
35. +T cells in vitro. Hum Immunol 61:357-365, 2000
36. + T-cells. Immunology 98:557-563, 1999
37. van der Vliet HJ: Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods 247:61-72, 2001
38. Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S: Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24:510-515, 2001